Viewing Study NCT00212277



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00212277
Status: COMPLETED
Last Update Posted: 2010-09-10
First Post: 2005-09-13

Brief Title: Efficacy and SafetyLong-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea
Sponsor: Nobelpharma
Organization: Nobelpharma

Study Overview

Official Title: Phase3Open-labelLong-termNSAID-Add-onClinical Trial of Mono-phase Low-dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis
Status: COMPLETED
Status Verified Date: 2010-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this long-term study is to determine whether combination oral contraceptive pill of Norethindrone Ethinyl estradiol is effective in the treatmentof dysmenorrhea associated with endometriosis
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None